Small Molecule-Mediated Stage-Specific Reprogramming of MSCs to Hepatocyte-Like Cells and Hepatic Tissue for Liver Injury Treatment
Stem Cell Reviews and Reports · 2024-11 · 20 (8) · 2215-2235
DOI: 10.1007/s12015-024-10771-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cell Reviews and Reports, online erschienen am 11.09.2024. Verfasst von Santosh Gupta und 5 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cell and Molecular Biology, Laboratory, Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technolog…. Hauptthemen laut MEDLINE: Hepatocytes, Mesenchymal Stem Cells, Cell Differentiation, Liver. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Oslo.
Abstract (Originalsprache)
Background
Derivation of hepatocytes from stem cells has been established through various protocols involving growth factor (GF) and small molecule (SM) agents, among others. However, mesenchymal stem cell-based derivation of hepatocytes still remains expensive due to the use of a cocktail of growth factors, and a long duration of differentiation is needed, thus limiting its potential clinical application.
Methods
In this study, we developed a chemically defined differentiation strategy that is exclusively based on SM and takes 14 days, while the GF-based protocol requires 23–28 days.
Results
We optimized a stage-specific differentiation protocol for the differentiation of rat bone marrow-derived mesenchymal stem cells (MSCs) into functional hepatocyte-like cells (dHeps) that involved four stages, i.e., definitive endoderm (DE), hepatic competence (HC), hepatic specification (HS) and hepatic differentiation and growth. We further generated hepatic tissue using human decellularized liver extracellular matrix and compared it with hepatic tissue derived from the growth factor-based protocol at the transcriptional level. dHep, upon transplantation in a rat model of acute liver injury (ALI), was capable of ameliorating liver injury in rats and improving liver function and tissue damage compared to those in the ALI model.
Conclusions
In summary, this is the first study in which hepatocytes and hepatic tissue were derived from MSCs utilizing a stage-specific strategy by exclusively using SM as a differentiation factor. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Stem Cell and Molecular Biology, Laboratory, Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai, Tamil Nadu, 600036, India. santosh.gupta@medisin.ui…
- Centre for Eye Research and Innovative Diagnostics, Department of Ophthalmology, Institute of Clinical Medicine, University of Oslo, Oslo, Norway. santosh.gupta@medisin.uio.no.
- Stem Cell and Molecular Biology, Laboratory, Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai, Tamil Nadu, 600036, India.
- The Institute of Liver Disease & Transplantation, Dr. Rela Institute & Medical Centre, Bharath Institute of Higher Education & Research, Chromepet, Tamil Nadu, India.
- Centre for Eye Research and Innovative Diagnostics, Department of Ophthalmology, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
- Stem Cell and Molecular Biology, Laboratory, Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai, Tamil Nadu, 600036, India. vermars@iitm.ac.in.
ORCID-Profile: Santosh Gupta
Förderung
- University of Oslo
Zitieren
APA
Gupta, S., Sharma, A., Rajakannu, M., Bisevac, J., Rela, M., & Verma, R. S. (2024). Small Molecule-Mediated Stage-Specific Reprogramming of MSCs to Hepatocyte-Like Cells and Hepatic Tissue for Liver Injury Treatment. Stem Cell Reviews and Reports, 20(8), 2215-2235. https://doi.org/10.1007/s12015-024-10771-x
Vancouver
Gupta S, Sharma A, Rajakannu M, Bisevac J, Rela M, Verma RS. Small Molecule-Mediated Stage-Specific Reprogramming of MSCs to Hepatocyte-Like Cells and Hepatic Tissue for Liver Injury Treatment. Stem Cell Reviews and Reports. 2024;20(8):2215-2235. doi:10.1007/s12015-024-10771-x
BibTeX
@article{Gupta2024,
author = {Gupta, Santosh and Sharma, Akriti and Rajakannu, Muthukumarassamy and Bisevac, Jovana and Rela, Mohamed and Verma, Rama Shanker},
title = {Small Molecule-Mediated Stage-Specific Reprogramming of MSCs to Hepatocyte-Like Cells and Hepatic Tissue for Liver Injury Treatment},
journal = {Stem Cell Reviews and Reports},
year = {2024},
volume = {20},
number = {8},
pages = {2215--2235},
doi = {10.1007/s12015-024-10771-x}
}
EUVIMED